Working to halt disease processes in the earliest stages

Initial Therapeutics, an ATP company, is discovering and developing a new class of small-molecule medicines designed to prevent pathogenic protein synthesis.

Initial’s approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.

Founded by world-renowned scientists, and currently operating in stealth mode with a substantial Series A commitment from ATP, Initial is pursuing high-confidence, heretofore difficult-to-drug targets in areas of serious unmet medical need.

Join the Initial team!

Initial Therapeutics is seeking scientists with expertise in molecular biology, cell biology, biochemistry, and synthetic and/or medicinal chemistry to join our South San Francisco-based team. See our current openings on LinkedIn.

Current Openings

Initial Therapeutics is founder-led and offers a dynamic start-up environment with a close-knit team of highly skilled, mission-driven professionals. We seek colleagues who are inspired to push the boundaries of small molecule discovery using novel approaches and who excel at identifying innovative solutions to challenging problems.

At Initial Therapeutics you’ll find a career where every day brings you adventures, challenges, and breakthroughs. Join a dynamic, diverse and growing team dedicated to developing transformative therapies that will revolutionize the future of disease treatment and outcomes. Initial offers a competitive compensation and benefits package.